KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 103 filers reported holding KYMERA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,560,461 | -36.6% | 3,925,213 | +4.9% | 0.00% | -50.0% |
| Q2 2023 | $86,053,593 | -22.2% | 3,743,088 | +0.2% | 0.00% | -33.3% |
| Q1 2023 | $110,636,198 | +21.1% | 3,733,925 | +2.0% | 0.00% | +50.0% |
| Q4 2022 | $91,361,262 | +46.6% | 3,660,307 | +27.8% | 0.00% | 0.0% |
| Q3 2022 | $62,332,000 | +10.1% | 2,863,177 | -0.4% | 0.00% | 0.0% |
| Q2 2022 | $56,604,000 | -52.9% | 2,874,724 | +1.3% | 0.00% | -33.3% |
| Q1 2022 | $120,092,000 | -36.0% | 2,837,725 | -4.0% | 0.00% | -25.0% |
| Q4 2021 | $187,751,000 | +10.2% | 2,957,174 | +1.9% | 0.00% | 0.0% |
| Q3 2021 | $170,438,000 | +71.9% | 2,901,574 | +41.9% | 0.00% | +100.0% |
| Q2 2021 | $99,144,000 | +47.3% | 2,044,224 | +18.0% | 0.00% | 0.0% |
| Q1 2021 | $67,318,000 | +74.3% | 1,732,345 | +178.0% | 0.00% | +100.0% |
| Q4 2020 | $38,631,000 | +156.5% | 623,060 | +33.7% | 0.00% | – |
| Q3 2020 | $15,058,000 | – | 466,050 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer IX & Co. Ltd. | 1,755,356 | $97,949,000 | 48.97% |
| Trustees of Columbia University in the City of New York | 463,298 | $28,724,000 | 38.38% |
| AJU IB Investment Co., Ltd. | 704,059 | $43,652,000 | 16.52% |
| BVF INC/IL | 2,630,658 | $163,101,000 | 6.42% |
| Redmile Group, LLC | 2,720,489 | $168,670,000 | 2.04% |
| Bain Capital Life Sciences Investors, LLC | 479,605 | $29,735,000 | 1.87% |
| Rock Springs Capital Management LP | 713,865 | $44,260,000 | 0.94% |
| SPHERA FUNDS MANAGEMENT LTD. | 147,700 | $9,157,000 | 0.81% |
| HighVista Strategies LLC | 17,117 | $1,061,000 | 0.68% |
| Logos Global Management LP | 110,920 | $6,877,000 | 0.59% |